GlassScriptPhysician profile
James W Howell
NPI 1346463866
$10,583.59
in general payments reported to CMS, 2019-2025
11 companies · $1,057 in 2025
The $1,057 reported for 2025 was more than what 87% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
See the full distribution for Oral and Maxillofacial Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,212 · 2020: $525 · 2021: $4,827 · 2022: $679 · 2023: $529 · 2024: $753 · 2025: $1,057.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,339.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,339.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $4,568.60 | 2019-2025 | |
| Stryker Corporation | $2,319.64 | 2019-2025 | Na, Medpor Titan, Vsp System, Vsp Cranial |
| Kls-Martin L.P. | $1,981.83 | 2019-2025 | |
| Biohorizons Implant Systems INC. | $907.55 | 2019-2024 | Biohorizons |
| Depuy Synthes Sales INC. | $258.96 | 2024-2025 | Trumatch, Matrixmidface, Matrixorthognathic |
| Zimvie INC. | $162.13 | 2023-2024 | |
| Henry Schein, INC. | $141.21 | 2023-2025 | |
| Salvin Dental Specialties, INC. | $128.21 | 2021 | |
| Zimmer Biomet Holdings, INC. | $58.11 | 2021 | |
| Planmeca USA, INC. | $38.66 | 2019 | |
| Nobel Biocare USA | $18.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Howell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.